Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne. Ncardia emerged from Pluriomics, a biotech company founded in 2001, and is a global reserach and development company in the field of applied stem cell technology with operations in Belgium, the Netherlands and the US. The Company’s goal is to assist science in the discovery and development of HiPSC medicines, including studies on cardiovascular and neuronal safety and efficacy.
